VLA 0.00% $1.75 viralytics limited

Ann: VLA to Present CAVATAK Bladder and Other Results at Conf., page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 128 Posts.
    lightbulb Created with Sketch. 3
    Wow.   The language is so extra-ordinarily up-beat for such early results.
    Viral tumour targeting, virus replication and evidence of tumour cell death …. From the lowest planned dose. Esp love that there is
    • an expectation of increased levels of CAvatak activity and
    • Optimism that …. (it) is likely to provide a strong signal in generating strong local and SYSTEMATIC!!!!!!!! Anti-tumour immune response.
    Have been amazed over a number of years that good announcments see no change to share price (and sometimes a fall) but it is REALLY hard to imagine share price increases to continue again for the week. Surely??   It has been such a long and tortuous road.   Maybe entering a straight.   The main straight????
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.